Codexis, Inc. (CDXS) Signs Deal to Supply Stereo-Defined siRNA Fragments
Codexis entered an agreement with a pioneering siRNA innovator to supply stereo-defined oligonucleotide fragments via its ECO Synthesis platform and compare them with SPOS for purity, quality, and ligation performance.Material DetailsContext by AI AnalystThis is an early-stage commercial validation…